HomeBig pharma not doing enough to improve drug access – analysisFILE PHOTO: A company logo is seen at the AstraZeneca

FILE PHOTO: A company logo is seen at the AstraZeneca

FILE PHOTO: A company logo is seen at the AstraZeneca site in Macclesfield, Britain, May 11, 2021. REUTERS/Phil Noble/File Photo

FILE PHOTO: A doctor tests a child for malaria at

Most Read

What Happens to the Stock Market After Elections? Sectors That Could Be Winners

October 19, 2024

Could Cameco Be Your Next Big Clean Energy Investment?

October 18, 2024

U.S. chip stocks rally as TSMC’s AI-backed outlook impresses investors

October 17, 2024

Google shifts Gemini app team to DeepMind

October 17, 2024